Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
Sign Up to like & getrecommendations! Published in 2022 at "Southern African Journal of HIV Medicine"
DOI: 10.4102/sajhivmed.v23i1.1452
Abstract: Background Dolutegravir, a component of the preferred first-line antiretroviral therapy regimen, has been associated with increased weight gain. South Africa has a high prevalence of obesity, especially among women. Understanding dolutegravir exposure in patients with… read more here.
Keywords: southern african; dolutegravir; obesity; dolutegravir exposure ... See more keywords